Shi Zihai, Deputy Director of the National Medical Insurance Administration, recently led a team to Tianjin to investigate the centralized procurement of high-value medical consumables by national organizations. He expressed the need to accelerate the promotion of the new batch of centralized procurement of high-value medical consumables by national organizations, and include high-value medical consumables such as cochlear implants in the procurement scope. Taking into full consideration the characteristics of the consumables market and clinical settings, research and improve the rules for centralized procurement.

At the same time, it is necessary to implement the results of the fourth batch of consumables centralized procurement, and the subsequent procurement and selection of results for artificial joints, to ensure that the selected products are admitted to hospitals in a timely manner and to guide and urge medical institutions to prioritize the procurement of selected products, ensuring that the people benefit in a real sense.